Interviews, articles, and industry contributions reflecting decades of pharmaceutical finance expertise.
Sudhir V. Valia's insights on corporate finance, pharmaceutical governance, and strategic leadership have been featured across leading business and industry publications.
Insights on managing financial strategy in research-intensive pharmaceutical organizations, balancing R&D investment with shareholder returns.
Industry Publication
Perspectives on the evolving landscape of corporate governance in India's pharmaceutical sector and the role of finance leaders in shaping organizational direction.
Business Media
Commentary on Sun Pharma's strategic positioning, market expansion initiatives, and the financial frameworks that enable sustainable global growth.
Conference & Summit
Beyond his executive roles, Sudhir V. Valia contributes to the broader discourse on corporate finance, pharmaceutical industry governance, and leadership excellence. His professional engagement spans industry forums, regulatory consultations, and knowledge-sharing initiatives that benefit the wider business community.
Sharing best practices in managing the financial complexities of research-driven pharmaceutical companies.
Insights on navigating India's evolving tax landscape and international tax frameworks for multinational operations.
Perspectives on effective board leadership, fiduciary responsibility, and the evolving role of directors in modern corporations.
"The pharmaceutical industry stands at the intersection of science, commerce, and public health. Those who lead its financial operations carry a unique responsibility — to ensure that the pursuit of innovation is sustained by sound fiscal stewardship."
Fellow Member (FCA) — the highest membership grade of ICAI, recognizing sustained excellence and contribution to the profession of chartered accountancy.
Active participation in pharmaceutical industry associations, corporate governance forums, and financial leadership networks across India and internationally.